Merger Notification - Announcement according to § 10 Cartel Act
Dechra Pharmaceuticals PLC; Luxinva S.A.
BWB/Z-6301
On 29.06.2023 the Austrian Federal Competition Authority was notified of the following merger:
Planned purchase process
Luxinva S.A., Luxembourg, an investment vehicle ultimately owned and controlled by the Abu Dhabi Investment Authority, Abu Dhabi, UAE, intends to indirectly acquire a non-controlling interest of more than 25% of the shares and votes in Dechra Pharmaceuticals PLC, United Kingdom.
Industry sector: C - Verarbeitendes Gewerbe/Herstellung von Waren
Deadline for bringing in an application pursuant to § 11(1) Cartel Act will end on 27.07.2023.
Entrepreneurs whose legal or economic interests are affected by the merger can bring in a written statement at the Federal Competition Authority or the Federal Cartel Prosecutor within 14 days from publication date.
Note: The intervening party has no right to a certain treatment of the statement and will not gain a party position.
Non-prohibition of the merger
The Federal Competition Authority and the Federal Cartel Prosecutor have not applied for examination of the merger by the Cartel Court. The standstill obligation (§ 17 (1) Cartel Act) ends with effect from 28.07.2023 .